Biological and Pharmaceutical Bulletin
Online ISSN : 1347-5215
Print ISSN : 0918-6158
ISSN-L : 0918-6158
The Induction of Interleukin-6 (IL-6) and Colony-Stimulating Factors (CSFs) by FK565 and Its Thrombopoietic Activity Following in Vivo Administration
Masahiro MAEDAShingo SUZUKIKazuyuki OHTSUKASusumu SATOHFusako NISHIGAKIKyoichi SHIMOMURAYuko IMAIMineo NIWAMasanobu KOHSAKA
Author information
JOURNALS FREE ACCESS

1994 Volume 17 Issue 2 Pages 173-179

Details
Abstract

The induction of macrophage colony-stimulating factor (M-CSF) in monkey plasma following administration of FK 565 was observed within 2 h of injection peaked at 4 h, and remained high after 24 h. Interleukin-6 (IL-6) and M-CSF levels increased in monkeys treated with FK565, even at doses as low as 0.01 mg/kg. Granulocyte CSF (G-CSF) levels increased slightly following a dose of 1 mg/kg, but granulocyte macrophage CSF (GM-CSF) was not detected at any doses of FK565 studied. To examine the thrombopoietic activity of FK565 in vivo, single doses of drug (0.01, 0.1 or 1.0 mg/kg) were administered i.v. to cynomolgus monkeys or normal mice on day 0. The promotes platelet (PLT) count after FK565 injection decreased transiently on days 1 and 2, and then increased in a dose-dependent manner on day 5 and was still high on day 14. The experiment using anti-PLT antibody showed that the increased PLT count was not simply due to a rebound phenomenon after the transient decrease in PLT. The effect of i.v. FK565 was studied in mice myelosuppressed with a single dose of mitomycin C (MMC) (5.6 mg/kg). The fall in PLT count was suppressed on day 7 by 0.1 and 1.0 mg/kg FK565. Although intact cells or tissues are necessary for an increase in PLT following FK565 treatment, FK565 suppressed the impaired hematopoietic function seen after chemotherapy. FK565 is proposed as a drug to restore reduced neutrophil and platelet counts found in AIDS or cancer therapy.

Information related to the author
© The Pharmaceutical Society of Japan
Previous article Next article
feedback
Top